Editas Medicine Inc (EDIT) — Cash Flow-to-Debt Ratio
Editas Medicine Inc (EDIT) has a Cash Flow-to-Debt Ratio of -0.22x as of June 2026, meaning its operating cash flow of $-29.57 Million could theoretically repay 0% of its total liabilities ($132.08 Million) in one year. See financial agility of Editas Medicine Inc to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Editas Medicine Inc Cash Flow-to-Debt Ratio (2013–2025)
Historical debt coverage capacity for Editas Medicine Inc across 13 annual periods. For the full cash flow conversion analysis, see Editas Medicine Inc (EDIT) cash conversion ratio.
Annual Cash Flow-to-Debt Ratio for Editas Medicine Inc (2013–2025)
Year-by-year debt coverage analysis for Editas Medicine Inc. Check Editas Medicine Inc (EDIT) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.04x | $-165.24 Million | $159.25 Million | ▼ -2.3% |
| 2024 | -1.01x | $-210.28 Million | $207.31 Million | ▼ -15.2% |
| 2023 | -0.88x | $-132.18 Million | $150.06 Million | ▲ +23.7% |
| 2022 | -1.15x | $-177.35 Million | $153.64 Million | ▲ +12.7% |
| 2021 | -1.32x | $-163.80 Million | $123.84 Million | ▼ -31.7% |
| 2020 | -1.00x | $-179.84 Million | $179.02 Million | ▼ -508.8% |
| 2019 | -0.17x | $-40.67 Million | $246.45 Million | ▲ +33.5% |
| 2018 | -0.25x | $-45.71 Million | $184.22 Million | ▼ -335.2% |
| 2017 | -0.06x | $-9.42 Million | $165.18 Million | ▲ +89.2% |
| 2016 | -0.53x | $-49.93 Million | $94.58 Million | ▼ -2171.4% |
| 2015 | -0.02x | $-5.40 Million | $232.48 Million | ▲ +92.6% |
| 2014 | -0.31x | $-8.65 Million | $27.48 Million | ▲ +52.0% |
| 2013 | -0.66x | $-2.78 Million | $4.24 Million | — |